These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12130713)

  • 1. Ischemia promotes renin activation and angiotensin formation in sympathetic nerve terminals isolated from the human heart: contribution to carrier-mediated norepinephrine release.
    Seyedi N; Koyama M; Mackins CJ; Levi R
    J Pharmacol Exp Ther; 2002 Aug; 302(2):539-44. PubMed ID: 12130713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of a renin-angiotensin system in ischemic cardiac sympathetic nerve endings and its association with norepinephrine release.
    Levi R; Silver RB; Mackins CJ; Seyedi N; Koyama M
    Int Immunopharmacol; 2002 Dec; 2(13-14):1965-73. PubMed ID: 12489810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors.
    Maruyama R; Hatta E; Yasuda K; Smith NC; Levi R
    J Pharmacol Exp Ther; 2000 Jul; 294(1):248-54. PubMed ID: 10871319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
    Foucart S; Patrick SK; Oster L; de Champlain J
    Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors.
    Brasch H; Sieroslawski L; Dominiak P
    Hypertension; 1993 Nov; 22(5):699-704. PubMed ID: 8225530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling of angiotensin II AT1 receptors to neuronal NHE activity and carrier-mediated norepinephrine release in myocardial ischemia.
    Reid AC; Mackins CJ; Seyedi N; Levi R; Silver RB
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1448-54. PubMed ID: 14684374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between the renin-angiotensin system (RAS) and the sympathetic system.
    Dendorfer A; Raasch W; Tempel K; Dominiak P
    Basic Res Cardiol; 1998; 93 Suppl 2():24-9. PubMed ID: 9833158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion.
    Mackins CJ; Kano S; Seyedi N; Schäfer U; Reid AC; Machida T; Silver RB; Levi R
    J Clin Invest; 2006 Apr; 116(4):1063-70. PubMed ID: 16585966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia.
    Sesti C; Koyama M; Broekman MJ; Marcus AJ; Levi R
    J Pharmacol Exp Ther; 2003 Jul; 306(1):238-44. PubMed ID: 12676879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Losartan, a nonpeptide angiotensin II receptor antagonist, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
    Suzuki Y; Matsumura Y; Egi Y; Morimoto S
    J Pharmacol Exp Ther; 1992 Dec; 263(3):956-63. PubMed ID: 1469652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria.
    Rump LC; Schwertfeger E; Schaible U; Fraedrich G; Schollmeyer P
    Circ Res; 1994 Mar; 74(3):434-40. PubMed ID: 8118951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin B2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings. Mediation by autocrine/paracrine mechanisms.
    Seyedi N; Win T; Lander HM; Levi R
    Circ Res; 1997 Nov; 81(5):774-84. PubMed ID: 9351450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release.
    Sesti C; Broekman MJ; Drosopoulos JH; Islam N; Marcus AJ; Levi R
    J Pharmacol Exp Ther; 2002 Feb; 300(2):605-11. PubMed ID: 11805223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium.
    Lenz O; Schmid B; Kilter H; La Rosée K; Flesch M; Kuhn-Regnier F; Südkamp M; Böhm M
    Eur J Pharmacol; 1995 Dec; 294(1):17-27. PubMed ID: 8788412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
    Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histamine 3 receptor activation reduces the expression of neuronal angiotensin II type 1 receptors in the heart.
    Hashikawa-Hobara N; Chan NY; Levi R
    J Pharmacol Exp Ther; 2012 Jan; 340(1):185-91. PubMed ID: 22011436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered effects of angiotensin ii type 1 and type 2 receptor blockers on cardiac norepinephrine release and inotropic responses during cardiac sympathetic nerve stimulation in aorto-caval shunt rats.
    Suzuki H; Maehara K; Yaoita H; Maruyama Y
    Circ J; 2004 Jul; 68(7):683-90. PubMed ID: 15226636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous angiotensin II does not facilitate norepinephrine release in the heart.
    Lameris TW; de Zeeuw S; Duncker DJ; Alberts G; Boomsma F; Verdouw PD; van den Meiracker AH
    Hypertension; 2002 Oct; 40(4):491-7. PubMed ID: 12364352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan.
    Shetty SS; DelGrande D
    J Pharmacol Exp Ther; 2000 Jul; 294(1):179-86. PubMed ID: 10871310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.